Back to results
US 2021/0061898 A1Published application
Treatment of fibrodysplasia ossificans progressiva
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsSarah J. Hatsell, Aris N. Economides, Vincent J. Idone
Life of this patent
Estimating the term…
Abstract
Methods for treating Fibrodysplasia Ossificans Progressiva (FOP) are provided in which a subject having FOP is administered an effective regime of an antibody against Activin B, BMP9 or BMP10.
Claims6
A method of treating Fibrodysplasia Ossificans Progressiva (FOP), comprising administering to a subject having FOP an effective regime of an antibody against Activin B, BMP9 or BMP10.
Dependencies are inferred from the claim text.